Pravastatin sodium

Cat. No.: OB0225WX-2546

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and HPLC.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Pravastatin sodium is an HMG-CoA reductase antagonist that suppresses the enzymatic synthesis of sterols with an IC50 of 5.6 μM.

Synonym: CS-514 Sodium; 81131-70-6; Mevalotin; Pravachol; Selektine; Elisor; Pravaselect; Lipostat; Pravastatin Sodium Salt; Eptastatin sodium; CS-514; Dehypotin protect; Pravastatin (sodium); Lipemol; Pravacol; Pravasin; MFCD00887601; Pravastatin (sodium) (Standard); Sodium;(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate; Aplactin; Lipidal; Liprevil; Pralidon; Pravasine; Sanaprav; Selipran; Vasen; Epastatin sodium; (3R,5R)-3,5-Dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-(((S)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoic acid, sodium salt; 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-, sodium salt (1:1), (betaR,deltaR,1S,2S,6S,8S,8aR)-; Sodium (+)-(betaR,deltaR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-hexahydro-beta,delta,6,8-tetrahydroxy-2-methyl-1-naphthaleneheptanoate, 8-((2S)-2-methylbutyrate); Sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-

CAS No.: 81131-70-6

Compound CID: 16759173

Formula: C₂₃H₃₅O₇·Na

Formula Weight: 446.51

Specification

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Pravastatin sodium is used in lipid metabolism research as a hydrophilic HMG-CoA reductase inhibitor to study the reduction of cholesterol biosynthesis and the prevention of atherosclerotic cardiovascular events.